BioSpace News Archive

Business

ONK Snags $21.5 Million for Natural Killer Cell Therapies

ONK announced an infusion of $21.5 million to propel their NK-powered programs towards IND-enabling studies.

January 6, 2022
·
2 min read
·
Kate Goodwin
Career Advice

9 Ways to Prevent Work From Home Burnout

Working from home can cause burnout and stress. The stress caused leads to low performance sometimes. Here are nine ways to prevent work from home burnout.

January 6, 2022
·
5 min read
·
Alina Zahid
Biotech Bay

New Biotech Earns $85 Million in Series A Funding

Ambagon Therapeutics closes its first financing round with $85 million. The Series A funds will help advance the company’s drug discovery platform and molecular glue pipeline.

January 6, 2022
·
2 min read
·
Alvin Clavines
Business

SomaLogic and Illumina Combine Strengths to Propel Innovation in Proteomics

SomaLogic and Illumina have come together to propel innovation in Proteomics. This partnership represents the rapidly growing high throughput sector of the proteomics market

January 6, 2022
·
2 min read
·
Sreetama Dutt
Drug Development

Sangamo Searching for Options After Sanofi Withdraws from SCD Program

Sangamo Therapeutics announced that Sanofi US was returning its rights to SAR445136 as it shifts its approach from personalized cell therapies to allogeneic off-the-shelf genomic approaches.

January 6, 2022
·
4 min read
·
Mark Terry
Business

Movers & Shakers, Jan. 7

With the turn of the calendar, biopharma and life sciences organizations have bolstered their leadership teams and board with these Movers & Shakers.

January 6, 2022
·
11 min read
·
Alex Keown
Drug Development

Cartesian Aims to Propel RNA Cell Therapy with Combinations

Long-term, opportunities may include using the platform as a vehicle for combination therapies from assets developed by multiple companies.

January 6, 2022
·
4 min read
·
Gail Dutton
Business

Gennao Bio Expands Leadership Team with Two Key Appointments

Gennao Bio today announced the appointments of Joseph W. McIntosh, M.D., as chief medical officer, and Anuj Goswami, J.D., MBA, as general counsel.

January 6, 2022
·
3 min read
Biotech Beach

Otonomy Reports Corporate and Product Pipeline Update

Otonomy, Inc. today provided an update on its product pipeline and financial guidance.

January 6, 2022
·
11 min read
Sensei Biotherapeutics Announces Executive Promotions

Sensei Biotherapeutics, Inc., an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, announced two key promotions within the company’s senior management team.

January 6, 2022
·
4 min read